BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 27113617)

  • 1. [One-year survival improvement in lung cancer in France. Results of the prospective real life studies KBP-2000-CPHG and KBP-2010-CPHG].
    Grivaux M; Duvert B; Ferrer-Lopez P; Hominal S; Goarant E; Brichet-Martin A; Romand P; Fournier E; Asselain B; Debieuvre D
    Rev Pneumol Clin; 2016 May; 72(3):163-70. PubMed ID: 27113617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence of slight improvement in five-year survival in non-small-cell lung cancer over the last 10 years: Results of the French KBP-CPHG real-world studies.
    Debieuvre D; Locher C; Asselain B; Dayen C; Molinier O; Falchero L; Dujon C; Delclaux B; Grivaux M
    Bull Cancer; 2019 Apr; 106(4):283-292. PubMed ID: 30803715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new face of non-small-cell lung cancer in men: Results of two French prospective epidemiological studies conducted 10 years apart.
    Debieuvre D; Oster JP; Riou R; Berruchon J; Levy A; Mathieu JP; Dumont P; Leroy-Terquem E; Tizon-Couetil V; Martin F; Grivaux M
    Lung Cancer; 2016 Jan; 91():1-6. PubMed ID: 26711927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ten-year evolution in non-small-cell lung cancer according to sex. Results of the KBP-2010-CPHG study by the College of General Hospital Respiratory Physicians].
    Debieuvre D; Locher C; Neidhardt AC; Goupil F; Lemaire B; Blanchet-Legens AS; Renault D; Tavernier JY; Tagu P; Mahmoud H; Figueredo M; Grivaux M
    Rev Mal Respir; 2014 Nov; 31(9):805-16. PubMed ID: 25433585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early mortality in lung cancer: French prospective multicentre observational study.
    Grivaux M; Debieuvre D; Herman D; Lemonnier C; Marcos JM; Crequit J; Vuillermoz-Blas S; Barre P; Saillour M; Martin F
    BMC Pulm Med; 2016 Apr; 16():45. PubMed ID: 27039176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five-year survival for lung cancer patients managed in general hospitals.
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prudhomme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2011 Sep; 28(7):e31-8. PubMed ID: 21943545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study KBP-2010-CPHG: inclusion of new cases of primary lung cancer diagnosed in general hospital pneumology departments between 1st January and 31 December 2010].
    Grivaux M; Locher C; Bombaron P; Collon T; Coëtmeur D; Dayen C; Debieuvre D; Goupil F; Le Treut J; Martin F; Molinier O; Asselain B; Zureik M; Blanchon F
    Rev Pneumol Clin; 2010 Dec; 66(6):375-82. PubMed ID: 21167448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapeutic strategies in patients undergoing surgery for non-small cell lung cancer. Results of the ESCAP-2011-CPHG study, promoted by the French College of General Hospital Respiratory Physicians (CPHG)].
    Pinquié F; Goupil F; Oster JP; Dixmier A; Renault PA; Lévy A; Mathieu JP; Paillot N; Goutorbe FC; Masson P; Molinier O; Debieuvre D; Grivaux M
    Rev Mal Respir; 2017 Nov; 34(9):976-990. PubMed ID: 29150179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between primary lung cancer and tobacco consumption. Results of the KBP-2010-CPHG study by the French College of General Hospital Respiratory Physicians].
    Coëtmeur D; Leveiller G; Frappat V; Martin M; Peureux M; Dehette S; Carbonnelle M; Dayen C; Debieuvre D; Grivaux M
    Rev Mal Respir; 2016 Sep; 33(7):583-93. PubMed ID: 26621000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major changes in lung cancer over the last ten years in France: the KBP-CPHG studies.
    Locher C; Debieuvre D; Coëtmeur D; Goupil F; Molinier O; Collon T; Dayen C; Le Treut J; Asselain B; Martin F; Blanchon F; Grivaux M
    Lung Cancer; 2013 Jul; 81(1):32-8. PubMed ID: 23541463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
    Debieuvre D; Fraboulet G; Duvert B; Piquet J; Goarant E; Sandron D; Mouroux-Rotomondo C; Borrel B; Genety C; Kassem GJ; Grivaux M
    Bull Cancer; 2017 Oct; 104(10):840-849. PubMed ID: 28965729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [First treatment strategies in the 2 years following lung cancer diagnosis. ESCAP-2011-CPHG, a real-life study carried out in French general hospitals].
    Grivaux M; Goupil F; Asselain B; Blanchon F; Collon T; Coëtmeur D; Dayen C; Locher C; Molinier O; Martin F; Debieuvre D
    Rev Mal Respir; 2017 Nov; 34(9):991-999. PubMed ID: 29111174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cohort KBP-2000-CPHG: Evaluation of factors influencing survival in lung cancer].
    Blanchon F; Grivaux M; Zureik M; Marsal L; Asselain B; Lebas FX; Orlando JP; Steenhouwer F; Benichou-Flurin M; Coëtmeur D; Collon T; David P; Delclaux B; Piquet J
    Rev Mal Respir; 2006 Apr; 23(2 Pt 1):165-71. PubMed ID: 16788443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer among women in France. Analysis of the 904 French women with lung cancer included in the KBP-2000-CPHG study of the French College of General Hospital-based Pneumologists (CPHG).
    Grivaux M; Breton JL; Bombaron P; Kuntz P; Lebas FX; Mehdaoui A; Herman D; David P; Berruchon J; Delclaux B; Zureik M; Blanchon F;
    Lung Cancer; 2004 Sep; 45(3):279-87. PubMed ID: 15301868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Five year survival for lung cancer patients managed in general hospitals].
    Grivaux M; Zureik M; Marsal L; Asselain B; Peureux M; Chavaillon JM; Prud'homme A; Carbonnelle M; Goarant E; Maury B; Bedossa A; Blanchon F
    Rev Mal Respir; 2009 Jan; 26(1):37-44. PubMed ID: 19212288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index.
    Blanchon F; Grivaux M; Asselain B; Lebas FX; Orlando JP; Piquet J; Zureik M
    Lancet Oncol; 2006 Oct; 7(10):829-36. PubMed ID: 17012045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and treatment costs of bone metastases from lung cancer: a French prospective, observational, multicenter study (GFPC 0601).
    Decroisette C; Monnet I; Berard H; Quere G; Le Caer H; Bota S; Audigier-Valette C; Geriniere L; Vernejoux JM; Chouaid C;
    J Thorac Oncol; 2011 Mar; 6(3):576-82. PubMed ID: 21270669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story?
    Erridge SC; Murray B; Williams L; Brewster D; Black R; Price A; Murray N; Sheehan F
    Lung Cancer; 2009 Jun; 64(3):358-66. PubMed ID: 19036470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are postoperative consequences of neoadjuvant chemotherapy for non-small cell lung cancer more severe in elderly patients?
    Rivera C; Jougon J; Dahan M; Falcoz PE; Bernard A; Brouchet L
    Lung Cancer; 2012 May; 76(2):216-21. PubMed ID: 22078278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.